“...but work calls.” So we know that GNBT has
Post# of 36566
(Total Views: 468)
Posted On: 10/18/2020 9:17:43 AM
“...but work calls.”
So we know that GNBT has many irons in the fire, particularly with covid/vaccine related activities of late. But we never really know what’s going on...with the peptide investigation, ongoing contract negotiations, funding...crickets. Things seem...hopeful. But we don’t know really. It’s a blank screen, full of ambiguity and uncertainty. So...I have one request for joe and his management team, something which would separate them from the competition. At the investor tab on the GNBT and NGIO websites, list each of their ongoing initiatives and give us a project management update each week...a Gantt chart...of progress made to date, or not made as the case may be. Take the uncertainty out of it, good or bad. Create a cadre of well-informed investors. How can it hurt for us to know why Joe went to NYC and his business objectives for making the trip. And then next week update us...on the Gantt chart...how it went. Just a thought.
Pros and cons?
So we know that GNBT has many irons in the fire, particularly with covid/vaccine related activities of late. But we never really know what’s going on...with the peptide investigation, ongoing contract negotiations, funding...crickets. Things seem...hopeful. But we don’t know really. It’s a blank screen, full of ambiguity and uncertainty. So...I have one request for joe and his management team, something which would separate them from the competition. At the investor tab on the GNBT and NGIO websites, list each of their ongoing initiatives and give us a project management update each week...a Gantt chart...of progress made to date, or not made as the case may be. Take the uncertainty out of it, good or bad. Create a cadre of well-informed investors. How can it hurt for us to know why Joe went to NYC and his business objectives for making the trip. And then next week update us...on the Gantt chart...how it went. Just a thought.
Pros and cons?
(4)
(0)